Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

8 results
  1. ... label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous ...
  2. ... NSAIDs) should be considered ahead of oral NSAIDs, cyclo-oxygenase-2 (COX-2) inhibitors or opioids. [2008] ...
  3. ... Wang H, et al. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from ... VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor ...
  4. ... chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and ... effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti- ...
  5. ... Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti- ... Rochon PA, Kopp A, Naglie G, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal ...
  6. ... effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti- ... A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding ...
  7. ... analyses (e.g., increased myocardial infarction risk with cyclo-oxygenase-2-selective non-steroidal anti-inflammatory agents). ... C, Dardavessis T, et al. The quality of safety reporting in trials is still suboptimal: survey of ...
  8. ... NSAIDs) should be considered ahead of oral NSAIDs, cyclo-oxygenase-2 (COX-2) inhibitors or opioids. [2008] ...